
  <style>
  .gh-table table { 
    border-collapse: collapse; 
    width: 100%;
    border: 1px solid #444;
    font-size: 12px;
  }
  .gh-table th, .gh-table td { 
    border: 1px solid #444; 
    padding: 4px 6px; 
    vertical-align: top;
    font-weight: 400 !important;   /* regular font */
  }
  .gh-table th { 
    .gh-table th { background: #f5f5f5; text-align: left; }
  }
  .gh-table th { font-weight: 700 !important; }
    @media print {
      .gh-table { font-size: 10px; }
    }
  </style>
  <div class='gh-table'><table><thead><tr><th>record_id</th><th>visit</th><th>Molecola (1)</th><th>Molecola (2)</th><th>description</th></tr></thead><tbody><tr><td>GER006</td><td>1</td><td>Dapagliflozin</td><td>Acetylsalicylic acid</td><td>The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid
is combined with Dapagliflozin.</td></tr><tr><td>GER006</td><td>1</td><td>Dapagliflozin</td><td>Insulin glargine</td><td>The risk or severity of hypoglycemia can be increased when Insulin glargine is
combined with Dapagliflozin.</td></tr><tr><td>GER006</td><td>1</td><td>Dapagliflozin</td><td>Quetiapine</td><td>The therapeutic efficacy of Dapagliflozin can be decreased when used in
combination with Quetiapine.</td></tr><tr><td>GER006</td><td>1</td><td>Dapagliflozin</td><td>Rosuvastatin</td><td>The therapeutic efficacy of Dapagliflozin can be increased when used in
combination with Rosuvastatin.</td></tr><tr><td>GER006</td><td>1</td><td>Dapagliflozin</td><td>Venlafaxine</td><td>The risk or severity of hypoglycemia can be increased when Venlafaxine is
combined with Dapagliflozin.</td></tr><tr><td>GER006</td><td>1</td><td>Ezetimibe</td><td>Pantoprazole</td><td>Pantoprazole may decrease the excretion rate of Ezetimibe which could result in
a higher serum level.</td></tr><tr><td>GER006</td><td>1</td><td>Ezetimibe</td><td>Venlafaxine</td><td>Venlafaxine may increase the excretion rate of Ezetimibe which could result in a
lower serum level and potentially a reduction in efficacy.</td></tr><tr><td>GER006</td><td>1</td><td>Insulin glargine</td><td>Acetylsalicylic acid</td><td>The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid
is combined with Insulin glargine.</td></tr><tr><td>GER006</td><td>1</td><td>Insulin glargine</td><td>Quetiapine</td><td>The therapeutic efficacy of Insulin glargine can be decreased when used in
combination with Quetiapine.</td></tr><tr><td>GER006</td><td>1</td><td>Insulin glargine</td><td>Rosuvastatin</td><td>The risk or severity of hypoglycemia can be increased when Rosuvastatin is
combined with Insulin glargine.</td></tr><tr><td>GER006</td><td>1</td><td>Metformin</td><td>Acetylsalicylic acid</td><td>The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid
is combined with Metformin.</td></tr><tr><td>GER006</td><td>1</td><td>Metformin</td><td>Insulin glargine</td><td>The risk or severity of adverse effects can be increased when Insulin glargine
is combined with Metformin.</td></tr><tr><td>GER006</td><td>1</td><td>Metformin</td><td>Pantoprazole</td><td>Pantoprazole may decrease the excretion rate of Metformin which could result in
a higher serum level.</td></tr><tr><td>GER006</td><td>1</td><td>Metformin</td><td>Quetiapine</td><td>The therapeutic efficacy of Metformin can be decreased when used in combination
with Quetiapine.</td></tr><tr><td>GER006</td><td>1</td><td>Metformin</td><td>Venlafaxine</td><td>The risk or severity of hypoglycemia can be increased when Venlafaxine is
combined with Metformin.</td></tr><tr><td>GER006</td><td>1</td><td>Pantoprazole</td><td>Acetylsalicylic acid</td><td>Acetylsalicylic acid may decrease the excretion rate of Pantoprazole which could
result in a higher serum level.</td></tr><tr><td>GER006</td><td>1</td><td>Pantoprazole</td><td>Rosuvastatin</td><td>The excretion of Rosuvastatin can be decreased when combined with Pantoprazole.</td></tr><tr><td>GER006</td><td>1</td><td>Quetiapine</td><td>Acetylsalicylic acid</td><td>The risk or severity of hypertension can be increased when Acetylsalicylic acid
is combined with Quetiapine.</td></tr><tr><td>GER006</td><td>1</td><td>Quetiapine</td><td>Pantoprazole</td><td>Pantoprazole may decrease the excretion rate of Quetiapine which could result in
a higher serum level.</td></tr><tr><td>GER006</td><td>1</td><td>Venlafaxine</td><td>Acetylsalicylic acid</td><td>Venlafaxine may increase the antiplatelet activities of Acetylsalicylic acid.</td></tr><tr><td>GER006</td><td>1</td><td>Venlafaxine</td><td>Insulin glargine</td><td>The risk or severity of hypoglycemia can be increased when Venlafaxine is
combined with Insulin glargine.</td></tr><tr><td>GER006</td><td>1</td><td>Venlafaxine</td><td>Pantoprazole</td><td>Pantoprazole may decrease the excretion rate of Venlafaxine which could result
in a higher serum level.</td></tr><tr><td>GER006</td><td>1</td><td>Venlafaxine</td><td>Quetiapine</td><td>The risk or severity of serotonin syndrome can be increased when Quetiapine is
combined with Venlafaxine.</td></tr><tr><td>GER006</td><td>1</td><td>Venlafaxine</td><td>Rosuvastatin</td><td>Venlafaxine may increase the excretion rate of Rosuvastatin which could result
in a lower serum level and potentially a reduction in efficacy.</td></tr></tbody></table></div>
